Neuropacs
PrivateLast Round
Seed
Jan 20, 2026
Total Funding Raised
$1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuropacs is a healthcare technology company that develops AI-driven diagnostic software to assist clinicians in evaluating and differentiating neurodegenerative forms of parkinsonism.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuropacs Comparables
Compare Neuropacs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SpinTech MRI | 81% | |
| Darmiyan | 80% | |
| Qynapse | 79% |
Neuropacs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 20, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 45% MoM.
- May 16, 2026
Monthly visitors grew 86% MoM, from 1.1K to 2K.
Neuropacs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neuropacs's valuation, stock price, and market status.
Is Neuropacs a public or private company?
Neuropacs is a private company.
What is the current stock price of Neuropacs?
Neuropacs is a private company, so its shares have no public market price. Caplight tracks Neuropacs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuropacs worth (valuation)?
Valuation information for Neuropacs is not publicly available.
Can I buy Neuropacs stock?
Neuropacs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuropacs's last funding round?
Neuropacs's most recent funding round was Seed on January 20, 2026.
Who are the main investors in Neuropacs?
Investor information for Neuropacs is not publicly disclosed.
Will Neuropacs IPO soon?
No public IPO plans have been announced for Neuropacs.
How can I track Neuropacs secondary market activity?
Caplight tracks bids, offers, and trades in Neuropacs's shares on secondary markets.